A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution

Patents for A61K 35 - Medicinal preparations containing material or reaction products thereof with undetermined constitution (125,838)
10/2002
10/10/2002	US20020146435 In ovo vaccination against coccidiosis
10/10/2002	US20020146423 Protective helicobacter antigens
10/10/2002	US20020146409 Providing a blood protein solution; adding hydroxypropyl-alpha -cyclodextrin in to form a stable complex with the protein; lyophilizing the solution of step to form a lyophilized protein/hydroxypropyl- alpha -cyclodextrin complex
10/10/2002	US20020146401 Harvesting animal tissue; lysing, homogenizing and filtering to produce extracts; fractionating to produce extracts and fractions; testing biological activity of extracts and fractions to select which induce differentiation
10/10/2002	US20020146396 Methods for use of apoptotic cells to deliver antigen to dendritic cells for induction or tolerization of T cells
10/10/2002	US20020146395 Methods of inducing nervous tissue regeneration
10/10/2002	US20020146393 EB Matrix Production from Fetal Tissues and its Use for Tissue Repair
10/10/2002	US20020146392 Helper dependent adenovirus vectors based on site-specific recombinases
10/10/2002	DE10117381A1 Herstellung polyklonaler, monospezifischer Antikörper gegen die uPAR-Varianten del4, del5 und del4+5 sowie deren Verwendung für diagnostische und therapeutische Zwecke Production of polyclonal, monospecific antibodies to uPAR variants del4, del5 and del4 + 5 and their use for diagnostic and therapeutic purposes
10/10/2002	DE10116362A1 Zwei-Komponenten Zusammensetzungen zur in situ Herstellung v. Fibroblasten und Keratinozyten umfassenden Zelltransplantaten Two-component compositions for v in situ production. Fibroblasts and keratinocytes comprehensive cell transplants
10/10/2002	DE10112851C1 Semi-allogene Antitumor-Vakzine mit HLA-haplo-identischen Antigen-präsentierenden Zellen Semi-allogeneic anti-tumor vaccine with HLA haplo-identical antigen presenting cells
10/10/2002	DE10108412A1 Ocular pigment epithelial cells, useful for treating e.g. macular degeneration by implantation, are transformed with large-capacity adenoviral vector
10/10/2002	CA2443355A1 Central nervous system neural progenitor cell which induces synapse-forming neurons in the spinal cord
10/10/2002	CA2442827A1 "a method for the preparation of immunologically inert amniotic membranes"
10/10/2002	CA2442734A1 Cartilaginous neo-tissue capable of being grafted
10/10/2002	CA2442732A1 Method for preparing a cartilaginous neo-tissue
10/10/2002	CA2442619A1 Cancer-testis antigens
10/10/2002	CA2442177A1 Method for transdifferentiation of non-pancreatic stem cells to the pancreatic differentiation pathway
10/10/2002	CA2442149A1 Viral vectors
10/10/2002	CA2441084A1 Improved conditionally replicating vectors for inhibiting viral infections
10/10/2002	CA2440108A1 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
10/10/2002	CA2437099A1 Methods and compositions for treatment of immune dysfunction disorders
10/10/2002	CA2437095A1 Methods and compositions for modulating the immune system of animals
10/10/2002	CA2433910A1 Antibiotics from bacteria isolated from amphibian skin
10/09/2002	EP1247779A2 Mast for a lift truck
10/09/2002	EP1247099A2 Methods and compositions for detecting hepatitis e virus
10/09/2002	EP1246930A1 Replication incompetent herpes virus vectors
10/09/2002	EP1246920A2 Prevention of affections associated with porcine circovirus-2
10/09/2002	EP1246903A1 Reconstructing organs from decellularized biomaterial scaffold
10/09/2002	EP1246901A1 Methods for protein transfer
10/09/2002	EP1246842A1 Nk cell receptor polynucleotides, polypeptides, and antibodies
10/09/2002	EP1246840A2 Human and parasite orphan receptor proteins
10/09/2002	EP1246789A1 Racemic and optically pure metabolites of sibutramine, their preparation, compositions comprising them and their use as dopamine reuptake inhibitors
10/09/2002	EP1246646A2 Enhancing the immune response to an antigen by presensitizing with an inducing agent prior to immunizing with the inducing agent and the antigen
10/09/2002	EP1246642A2 Use of a vector comprising a nucleic acid coding for an anti-angiogenic factor for treating corneal neovascularization
10/09/2002	EP1246634A1 Methods for treating pancreatic disorders
10/09/2002	EP1246631A1 Method and device for increasing and/or decreasing the concentration of immunomodulatory-active substances in substance mixtures
10/09/2002	EP1246538A1 Thickened oil compositions of edible oil
10/09/2002	EP1129208B1 Vancoresmycin, a process for its production and its use as a pharmaceutical
10/09/2002	EP1009411A4 Method and composition for treating sleep apnea
10/09/2002	EP0991416B1 A universally applicable blood plasma
10/09/2002	EP0973550B1 Antagonistic anti-avb3 integrin antibodies
10/09/2002	EP0967986B1 USE OF HUMAN alpha 1-ACID GLYCOPROTEIN FOR PRODUCING A PHARMACEUTICAL PREPARATION
10/09/2002	EP0914107B1 Compositions comprising lidocaine and emu oil and methods of use thereof
10/09/2002	EP0833620B1 Fgfr3 as a marker for mesenchymal skeletal progenitor cells
10/09/2002	EP0825863B1 Method for reducing intraocular pressure in the mammalian eye by administration of potassium channel blockers
10/09/2002	EP0625206B1 Human epidermal gene promoter
10/09/2002	CN1373804A Conditional immortalisation of cells
10/09/2002	CN1373659A Solid lipid formulations
10/09/2002	CN1372984A Health-care physiotherapeutic pearl blanket (mattress, quilt and bed sheet)
10/09/2002	CN1372969A Medical liquor for treating rheuamtic arthritis ischias, etc
10/09/2002	CN1372956A Medicine for treating pulmonary tuberculosis and its preparing process
10/09/2002	CN1372955A Oral liquid 'Gubao' and its preparing process
10/09/2002	CN1372953A Capsule for treating hepatism
10/09/2002	CN1372952A Cigarette for dropping drug and its addition and building body up and its preparing process
10/09/2002	CN1372951A Chinese mediicne composition for regenerating hair
10/09/2002	CN1372941A Staphylococcus aureus metabolin gel and its preparing process
10/09/2002	CN1372940A Chinese medicine for treating cerebral haemorrhage
10/09/2002	CN1372939A Nursing pearl mattress (blanket, quilt and bed sheet) for infant
10/09/2002	CN1372792A Technique for taking toxin from spider
10/09/2002	CN1092069C Recombinant vaccine for diseases caused by encapsulated organisms
10/09/2002	CN1092068C Medicine for treatment of tinea
10/09/2002	CN1092066C Analgesic plaster for osteoarthritis
10/09/2002	CN1092062C Chinese medicine for treating vascular headache
10/09/2002	CN1092060C Ointment for exterior use for treating burns and scalds
10/09/2002	CN1092059C Medicine for treating toxoplasmosis
10/09/2002	CN1092056C Chinese medicine 'Kaibitong' for treating rheumatism
10/09/2002	CN1092054C Medicine pill for detoxicating, killing bacteria anjd relieving inflammation
10/09/2002	CN1092052C Whole deer preparation
10/09/2002	CN1092051C Tech for preparing ointment for treating burns and scalds
10/09/2002	CN1092038C Giant silkworm silk nutrition skin-protection product
10/09/2002	CN1092026C Pure traditional Chinese medicine fodder additives
10/08/2002	US6461869 Purging leukemia cells from hematopoietic stem cells
10/08/2002	US6461867 Synthetic antigen presenting matrix
10/08/2002	US6461645 Cryopreserved pharmaceutical composition comprising viable human neonatal or fetal hematopoietic stem cells derived from umbilical cord or placental blood of single human collected at birth, cryopreservative, carrier
10/08/2002	US6461608 E. coli
10/08/2002	US6461607 Probiotic, lactic acid-producing bacteria and uses thereof
10/04/2002	CA2342708A1 Methods for inhibiting cancer growth, reducing infection and promoting general health with a fermented soy extract
10/03/2002	WO2002077336A1 Methods for forming hardened tubes and sheets
10/03/2002	WO2002077249A2 Type iii bacterial strains for use in medicine
10/03/2002	WO2002077217A2 Human dual specificity protein phosphatase 7-like protein
10/03/2002	WO2002077208A1 Antigen-dependent reduction of specific immune reactions by influencing the co-stimulation
10/03/2002	WO2002077204A2 Stem cell differentiation
10/03/2002	WO2002077029A2 Cd19-specific redirected immune cells
10/03/2002	WO2002077027A1 Human stra6-like protein and nucleic acids encoding the same
10/03/2002	WO2002076508A1 Methods for delivering nucleic acid molecules into cells and assessment thereof
10/03/2002	WO2002076488A1 Human secreted proteins
10/03/2002	WO2002076475A2 Glycosaminoglycan anticoagulants derived from fish
10/03/2002	WO2002076471A1 Composition comprising a prebiotic for decreasing inflammatory process and abnormal activation of non-specific immune parameters
10/03/2002	WO2002076468A1 Tumor therapy with alphavirus-based and high affinity laminin receptor-targeted vectors
10/03/2002	WO2002076433A1 Dental formulation
10/03/2002	WO2002076391A2 Microbial feeds for aquaculture and agriculture
10/03/2002	WO2002076386A2 Method of inducing proliferation of retinal stem cells
10/03/2002	WO2002076380A2 Cytotoxic factors for modulating cell death
10/03/2002	WO2002076337A2 Xenograft bone matrix for orthopedic applications
10/03/2002	WO2002076285A2 Composition and methods fro the production of biological tissues and tissue constructs
10/03/2002	WO2002076240A1 Health foods containing natto kinase and fermented milk porducts
10/03/2002	WO2002076223A1 A probiotic, a food product containing a probiotic, a method for preparation of said food product, a pharmaceutical composition and a use of the probiotic strain
10/03/2002	WO2002076216A1 Viral vectors and their use in therapeutic methods
10/03/2002	WO2002062359B1 Preparation of cartilage extracts using organic solvents

1 ... 944 945 946 947 948 949 950 951 952 953 954 955 956 957 958 959 960 961 962 963 964 ... 1259